Amg National Trust Bank Organon & Co. Transaction History

Amg National Trust Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$16.59 - $23.77 $132 - $190	8 Added 0.01%	65,211 $1.13 Million
Q2 2023 Aug 02, 2023	SELL	$19.27 - $24.63 $13,026 - $16,649	-676 Reduced 1.03%	65,203 $1.36 Million
Q1 2023 May 10, 2023	BUY	$21.42 - $32.08 $455,774 - $682,598	21,278 Added 47.71%	65,879 $1.55 Million
Q4 2022 Feb 07, 2023	BUY	$23.31 - $28.61 $158,414 - $194,433	6,796 Added 17.98%	44,601 $1.25 Million
Q3 2022 Nov 03, 2022	BUY	$23.4 - $34.25 $199,040 - $291,330	8,506 Added 29.03%	37,805 $885,000
Q2 2022 Aug 05, 2022	SELL	$31.66 - $38.9 $3,039 - $3,734	-96 Reduced 0.33%	29,299 $986,000
Q1 2022 May 10, 2022	BUY	$30.45 - $39.36 $895,077 - $1.16 Million	29,395 New	29,395 $1.03 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Amg National Trust Bank with notifications on news.